KureCare has announced a wound care platform combining advanced regenerative treatments with Medicare billing support and provider training. The system connects patients with chronic wounds to certified specialists offering biologics-based care covered under Medicare guidelines.
-- KureCare has announced the launch of its integrated wound care platform designed to connect patients experiencing non-healing wounds with regenerative treatment providers across the United States. The system addresses treatment access for diabetic foot ulcers, venous leg ulcers, pressure injuries, and slow-healing surgical wounds.
To learn more about the platform and treatment options, go to https://curewounds.com
The platform launch comes as Medicare prepares to implement significant coverage changes for wound care treatments beginning January 1, 2026. The new policy will introduce stricter clinical requirements, including mandatory four-week standard care periods before advanced treatment qualifications and limitations on the number of covered applications per treatment episode.
According to KureCare, their system includes real-time analytics and patient progress tracking accessible through a provider dashboard. It also allows treatment providers to monitor wound healing rates, manage documentation requirements, and access billing templates designed for Medicare compliance.
"Chronic wounds represent a significant healthcare challenge, particularly for patients with diabetes and circulation issues," stated Kenton Gray, Kure Care's Founder and CEO. "This platform brings together the clinical tools, compliance support, and patient resources that providers need to deliver advanced wound care."
For patients, the platform offers an eligibility assessment tool that helps determine Medicare coverage qualification before beginning treatment. Coverage verification typically processes within 24 hours for patients meeting clinical criteria. The system includes a provider locator that shows certified wound care specialists by geographic area.
The treatment approach centers on regenerative biologics applied in outpatient settings with initial patient assessments including wound evaluation and medical history review to develop treatment plans. Follow-up appointments involve monitoring healing progress and adjusting protocols based on response to treatment.
Provider support includes training on biologics application, Medicare billing procedures, and regulatory compliance. The system incorporates documentation templates and pre-authorization checklists designed to meet Medicare requirements for wound care treatments.
The KureCare platform is currently available to healthcare providers and patients nationwide. For more information about eligibility, provider locations, or the platform's capabilities, visit https://curewounds.com
Contact Info:
Name: Kenton Gray
Email: Send Email
Organization: Kure Care a division of Veracor Group LLC
Address: 1150 NW 72ND AVE TOWER 1 STE 455 #20073 , Miami, FL 33126, United States
Website: https://curewounds.com
Source: PressCable
Release ID: 89175565
If there are any deficiencies, discrepancies, or concerns regarding the information presented in this press release, we kindly request that you promptly inform us by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team is committed to addressing any identified issues within 8 hours to guarantee the delivery of accurate and reliable content to our esteemed readers.
